Literature DB >> 26475989

Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid.

Kelly N Messingham1, Jeffrey W Wang1, Heather M Holahan1, Rupasree Srikantha1, Samantha C Aust1, Janet A Fairley1,2.   

Abstract

Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by antibodies (IgG and IgE) targeting cell-substrate adhesion proteins. A variety of BP models suggest that autoantibody-dependent neutrophil degranulation is essential for blister formation. However, lesional biopsies reveal a predominance of eosinophils and few neutrophils. Our goal was to evaluate the role of antibodies and complement in eosinophil localization, degranulation and split formation at the dermo-epidermal junction (DEJ) utilizing a human skin cryosection model of BP paired with a human eosinophilic cell line, 15HL-60. Expression of receptors for IgG (FcγRII), IgE (FcεRI) and complement (CR1 and CR3) was confirmed on 15HL-60 cells using flow cytometry. 15HL-60 expression of granule protein [eosinophil derived neurotoxin (EDN) and eosinophil peroxidase (EPO)] mRNA and their degranulation in vitro was confirmed using RT-PCR and ELISA, respectively. For cryosection experiments, BP or control sera or IgG and IgE antibodies purified from BP sera were utilized in combination with 15HL-60 cells ± fresh complement. Both BP serum and fresh complement were required for localization of 15-HL60 cells to the DEJ. Interestingly, eosinophil localization to the DEJ was dependent on IgG, but not IgE, and complement. However, no subepidermal split was observed. Additionally, the 15HL-60 cells did not degranulate under any experimental conditions and direct application of cell lysate to cryosections did not result in a split. Our observation that eosinophil localization to the DEJ is dependent on IgG mediated complement fixation provides additional insight into the sequence of events during the development of BP lesions.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  autoantibody; bullous; eosinophil; human; skin

Mesh:

Substances:

Year:  2015        PMID: 26475989      PMCID: PMC4730885          DOI: 10.1111/exd.12883

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  47 in total

1.  Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.

Authors:  Ken Natsuga; Wataru Nishie; Satoru Shinkuma; Hideyuki Ujiie; Machiko Nishimura; Daisuke Sawamura; Hiroshi Shimizu
Journal:  J Immunol       Date:  2012-04-20       Impact factor: 5.422

2.  Why human pemphigoid autoantibodies do not trigger disease by the passive transfer into mice?

Authors:  Alina Sesarman; Eva Oswald; Mircea T Chiriac; Kinga Csorba; Vlad Vuta; Vasile Feldrihan; Adrian Baican; Leena Bruckner-Tuderman; Cassian Sitaru
Journal:  Immunol Lett       Date:  2012-01-25       Impact factor: 3.685

3.  Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid.

Authors:  Lan Lin; Tomoko Betsuyaku; Lisa Heimbach; Ning Li; David Rubenstein; Steven D Shapiro; Lijia An; George J Giudice; Luis A Diaz; Robert M Senior; Zhi Liu
Journal:  Matrix Biol       Date:  2011-09-25       Impact factor: 11.583

4.  Humanization of autoantigen.

Authors:  Wataru Nishie; Daisuke Sawamura; Maki Goto; Kei Ito; Akihiko Shibaki; James R McMillan; Kaori Sakai; Hideki Nakamura; Edit Olasz; Kim B Yancey; Masashi Akiyama; Hiroshi Shimizu
Journal:  Nat Med       Date:  2007-02-25       Impact factor: 53.440

5.  IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice.

Authors:  John J Zone; Ted Taylor; Christopher Hull; Linda Schmidt; Laurence Meyer
Journal:  J Invest Dermatol       Date:  2007-01-18       Impact factor: 8.551

Review 6.  Eosinophil granule proteins: form and function.

Authors:  K Ravi Acharya; Steven J Ackerman
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

7.  Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

Authors:  Zhi Liu; Wen Sui; Minglang Zhao; Zhuowei Li; Ning Li; Randy Thresher; George J Giudice; Janet A Fairley; Cassian Sitaru; Detlef Zillikens; Gang Ning; M Peter Marinkovich; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-14       Impact factor: 7.094

8.  A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid.

Authors:  Kelly A N Messingham; Megan H Noe; Marisa A Chapman; George J Giudice; Janet A Fairley
Journal:  J Immunol Methods       Date:  2009-05-05       Impact factor: 2.303

9.  A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice.

Authors:  Janet A Fairley; Christopher T Burnett; Chang-Ling Fu; David L Larson; Matthew G Fleming; George J Giudice
Journal:  J Invest Dermatol       Date:  2007-07-05       Impact factor: 8.551

10.  IgG4 autoantibodies induce dermal-epidermal separation.

Authors:  Sidonia Mihai; Mircea T Chiriac; Josep E Herrero-González; Margaret Goodall; Roy Jefferis; Caroline O S Savage; Detlef Zillikens; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

View more
  11 in total

Review 1.  Ocular mucous membrane pemphigoid: a review.

Authors:  Samanta Taurone; Marialuisa Spoletini; Massimo Ralli; Pietro Gobbi; Marco Artico; Laszlò Imre; Cecília Czakò; Illés Kovàcs; Antonio Greco; Alessandra Micera
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

3.  Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome.

Authors:  Delphine Giusti; Gregory Gatouillat; Sébastien Le Jan; Julie Plée; Philippe Bernard; Frank Antonicelli; Bach Nga Pham
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

Review 4.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

Review 5.  Eosinophils in Autoimmune Diseases.

Authors:  Nicola L Diny; Noel R Rose; Daniela Čiháková
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

Review 6.  The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid.

Authors:  Kelly N Messingham; Tyler P Crowe; Janet A Fairley
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

7.  Mechanistic Understanding of Cell Recognition and Immune Reaction via CR1/CR3 by HAP- and SiO2-NPs.

Authors:  Tingting Ding; Jiao Sun
Journal:  Biomed Res Int       Date:  2020-04-21       Impact factor: 3.411

Review 8.  Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms.

Authors:  Connor Cole; Keshavamurthy Vinay; Luca Borradori; Kyle T Amber
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

9.  Explosive bullous pemphigoid with high serum total IgE: Serum IgE as a biomarker that reflects disease activity.

Authors:  Hyun Jung Kwon; Ga Ram Ahn; Sun Young Choi; Kapsok Li; Seong Jun Seo
Journal:  JAAD Case Rep       Date:  2018-04-04

10.  IgE autoantibodies in serum and skin of non-bullous and bullous pemphigoid patients.

Authors:  A Lamberts; N Kotnik; G F H Diercks; J M Meijer; G Di Zenzo; H H Pas; M F Jonkman; B F Gibbs; U Raap; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-11-17       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.